Restoring Veeva Systems to Watch List

With Q1 sales growth of almost 24%, Veeva has returned to the Green Screens and will return to the Watch List as well. This specialized pharmaceutical SaaS provider continues to have an outstanding economic moat, and growth is re-accelerating after a few slow years. My fair value estimate is $186. The stock trades a touch below that at present, making this one a close watch for Buy List addition in the near future.

Watch List

APPF -3.02%
CMG 43.83%
VEEV 16.09%
INTU 19.56%
WDAY -7.52%
PSTG -0.65%
RDDT 18.10%
NTNX 24.37%
CRWD 94.01%
SE 26.50%
SNOW 13.14%

Buy List

PINS -36.44%
SEMR -33.35%
TSM -40.82%
ZETA -27.00%
GOOG -49.43%
NYAX -28.98%
MSFT -28.62%
ODD -29.76%
FLYW -42.32%
HRMY -59.44%
YOU -38.27%
ABNB -31.17%
ADBE -42.81%

Hold List

ASML -22.86%
VTEX -14.24%
ASR -23.26%
CELH 46.96%
TOST 20.33%
CPNG -11.55%
HIMS -19.74%
PAYC -18.13%
MNDY 18.61%
GLBE -21.26%
ZS 32.26%
V -7.16%
ADSK -0.03%
NOW 14.16%
MELI -23.30%
FTNT -0.20%
TEAM 0.30%